Efficacy of Multimodality Approach in Patients With Recurrent Head and Neck Squamous Cell Carcinoma.

Hoell, PA; Elsayad, K; Berssenbruegge, H; Hering, D; Kittel, C; Kleinheinz, J; Bleckmann, A; Evers, G; Wardelmann, E; Rudack, C; Eich, HT (2023)

In: Anticancer Research, 43(3).

Research article (journal)

Ultrahypofractionated Low-Dose Total Skin Electron Beam in Advanced-Stage Mycosis Fungoides and Sézary Syndrome

Elsayad K, Weishaupt C, Moustakis C, Danzer MF, Müller EC, Rolf D, Stranzenbach R, Livingstone E, Booken N, Stadler R, Eich HT (2023)

In: International Journal of Radiation Oncology - Biology - Physics, 117(1).

Research article (journal)

Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast Cancer

Troschel FM, Minte A, Ismail YM, Kamal A, Abdullah MS, Ahmed SH, Deffner M, Kemper B, Kiesel L, Eich HT, Ibrahim SA, Götte M, Greve B. (2020)

In: International Journal of Molecular Sciences, 21(6).

Research article (journal)

Worth a local treatment? - Analysis of modern radiotherapy concepts for oligometastatic prostate cancer

Oertel M, Scobioala S, Kroeger K, Baehr A, Stegger L, Haverkamp U, Schäfers M, Eich H-T (2018)

In: Radiation Oncology, 13(185).

Research article (journal)

Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): An open-label, international, randomised phase 3 study by the German Hodgkin Study Group

Borchmann P., Haverkamp H., Lohri A., Mey U., Kreissl S., Greil R., Markova J., Feuring-Buske M., Meissner J., Dührsen U., Ostermann H., Keller U., Maschmeyer G., Kuhnert G., Dietlein M., Kobe C., Eich H., Baues C., Stein H., Fuchs M., Diehl V., Engert A. (2017)

In: Lancet Oncology, null(null).

Research article (journal)

Publications

Contact

Top-Links

Efficacy of Multimodality Approach in Patients With Recurrent Head and Neck Squamous Cell Carcinoma. Hoell, PA; Elsayad, K; Berssenbruegge, H; Hering, D; Kittel, C; Kleinheinz, J; Bleckmann, A; Evers, G; Wardelmann, E; Rudack, C; Eich, HT (2023) In: Anticancer Research, 43(3). Research article (journal)
Radiotherapeutic Treatment of indolent cutaneous B-cell Lymphomas - Results of a multicenter Registry Oertel, Michael; Storck, Michael; Goerlich, Dennis; Schnellhardt, Soeren; Bock, Felix; Linde, Philipp; Domschikowski, Justus; Peeken, Jan; Wittig, Andrea; Elsayad, Khaled; Siats, Jan; Rolf, Daniel; Combs, Stephanie E.; Baues, Christian; Dunst, Juergen; Hildebrandt, Guido; Fietkau, Rainer; Eich, Hans Theodor (2023) In: Strahlentherapie und Onkologie, 199. Research article (journal)
Ultrahypofractionated Low-Dose Total Skin Electron Beam in Advanced-Stage Mycosis Fungoides and Sézary Syndrome Elsayad K, Weishaupt C, Moustakis C, Danzer MF, Müller EC, Rolf D, Stranzenbach R, Livingstone E, Booken N, Stadler R, Eich HT (2023) In: International Journal of Radiation Oncology - Biology - Physics, 117(1). Research article (journal)
Reduction of tumor volume during radiotherapy in patients with small-cell lung cancer and its prognostic significance. Kandler C; Elsayad K; Evers G; Siats J; Kittel C; Scobioala S; Bleckmann A; Eich HT (2023) In: Strahlentherapie und Onkologie, 199(11). Research article (journal)
Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast Cancer Troschel FM, Minte A, Ismail YM, Kamal A, Abdullah MS, Ahmed SH, Deffner M, Kemper B, Kiesel L, Eich HT, Ibrahim SA, Götte M, Greve B. (2020) In: International Journal of Molecular Sciences, 21(6). Research article (journal)
Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma Brand V, Greve B, Bölling T, Eich HT, Willich N, Harrach S, Hintelmann H, Lenz G, Mesters RM, Kessler T, Schliemann C, Berdel WE, Schwöppe C (2020) In: PloS one, 15(2). Research article (journal)
Worth a local treatment? - Analysis of modern radiotherapy concepts for oligometastatic prostate cancer Oertel M, Scobioala S, Kroeger K, Baehr A, Stegger L, Haverkamp U, Schäfers M, Eich H-T (2018) In: Radiation Oncology, 13(185). Research article (journal)
Quality control of involved field radiotherapy in the HD 13 and HD 14 trials: Report of the radiotherapy panel of the German Hodgkin Study Group (GHSG) Kriz J., Baues C., Engenhart-Cabillic R., Haverkamp U., Herfart K., Lukas P., Plütschow A., Schmidberger H., Staar S., Fuchs M., Engert A., Eich H. (2017) In: Strahlentherapie und Onkologie, 193(2). Research article (journal)
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): An open-label, international, randomised phase 3 study by the German Hodgkin Study Group Borchmann P., Haverkamp H., Lohri A., Mey U., Kreissl S., Greil R., Markova J., Feuring-Buske M., Meissner J., Dührsen U., Ostermann H., Keller U., Maschmeyer G., Kuhnert G., Dietlein M., Kobe C., Eich H., Baues C., Stein H., Fuchs M., Diehl V., Engert A. (2017) In: Lancet Oncology, null(null). Research article (journal)
New quality assurance program integrating “modern radiotherapy” within the German Hodgkin Study Group Kriz J., Baues C., Engenhart-Cabillic R., Haverkamp U., Herfarth K., Lukas P., Schmidberger H., Marnitz-Schulze S., Fuchs M., Engert A., Eich H. (2017) In: Strahlentherapie und Onkologie, 193(2). Research article (journal)